Application and inspection preparation
Map requirements, responsibilities and evidence before formal scrutiny exposes avoidable gaps.
Medicines & Healthcare products Regulatory Agency
MHRA scrutiny needs controlled evidence, not last-minute paperwork.
We help healthcare organisations understand the regulatory gap, organise accountable evidence and move through applications, operational change or corrective action with a clearer plan.
Who the MHRA is
The regulator of the product, and the system that controls it.
The Medicines and Healthcare products Regulatory Agency is the government body responsible for making sure medicines, medical devices and blood components meet expected standards of safety, quality and performance. It is an executive agency of the Department of Health and Social Care.
Its reach is wider than most organisations expect. The MHRA grants the licences that allow certain activities to take place at all, inspects the sites carrying them out, and can restrict, suspend or stop activity where confidence is lost. Where CQC looks at the quality of care, the MHRA looks at the product, the process behind it and the people accountable for both.
Most organisations meet that reality late: at launch, during due diligence, or when an inspection date lands in the diary.
When to involve us
Before a regulatory question becomes an operational delay.
MHRA-facing work can cut across quality systems, clinical practice, product handling, reporting and senior accountability. A weakness in one area can undermine confidence in the whole position.
We bring structure to that complexity: identifying what matters, who owns it and what evidence must be strengthened before the next decision point.
MHRA support
Practical help at the points where risk concentrates.
The exact scope is shaped around your activity, current position and timetable. The aim is a defensible operating picture, not a generic compliance pack.
Quality and medicines controls
Clarify oversight, escalation, record keeping and management assurance across the operating model.
Medical device pathways
Structure the questions, documentation and internal ownership around device-related activity and change.
Findings and corrective action
Turn concerns into prioritised actions with named owners, evidence expectations and realistic deadlines.
New services and transactions
Test whether regulatory dependencies have been understood before launch, acquisition or investment decisions are fixed.
Leadership briefing
Give boards and senior teams a concise view of exposure, decisions and progress.
A flavour of the ground
Where scrutiny tends to land.
The questions below are a small extract from a much longer working list. They are the kind of thing an inspector reaches for once the policies have been read, and the point at which a confident answer either exists or does not.
Complaints, trends and corrective action
- Does a complaint reliably become an investigation, and does that investigation reach a conclusion anyone would defend?
- Is trend data produced often enough to be useful, and can you show that senior leaders actually acted on it?
Identity, status and justification
- Is the status of material unambiguous at every point in its life, and could you reconstruct it months later?
- Can your specifications, sampling and testing be justified for what you actually make, rather than what a template assumed?
Records, control and the shop floor
- Does batch documentation genuinely reconstruct the journey to release, or simply record the outcome?
- Do controlled documents describe how the process is really run, including the checks and reconciliation people rely on?
- Are clearance and segregation described, done and evidenced? Those three have a habit of drifting apart.
Contamination control and monitoring
- Where sterility is at stake, is contamination control a defined position, and is aseptic behaviour something you can demonstrate, not assert?
- Is environmental monitoring designed, escalated and reviewed in a way that would hold up under questioning?
This is a fraction of what we work through, and deliberately so. The full picture depends on your licence, your product range and how your organisation actually behaves on a difficult day, which is the part we help you get right. Talk through your position
A controlled route
See the position. Set the priorities. Evidence the response.
Define the regulatory question
We establish the activity, decision point, stakeholders and immediate constraints.
Review the operating evidence
We work through our full review list, testing the documents, controls and accountability behind the stated position.
Build the action route
You receive a focused plan for readiness, remediation or senior assurance.
Unsure whether your issue sits with CQC, MHRA, or both?
Start with the situation. We’ll help identify the right regulatory route.